WallStreetZenWallStreetZen

NASDAQ: FDMT
4d Molecular Therapeutics Inc Stock Ownership - Who owns 4d Molecular Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have 4d Molecular Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Ashoo GuptaVP Finance and Controller2026-03-20310$8.61
$2.67kSell
Ashoo GuptaVP Finance and Controller2026-03-2080$8.61
$688.80Sell
Ashoo GuptaVP Finance and Controller2025-12-2079$8.68
$685.72Sell
Ashoo GuptaVP Finance and Controller2025-12-20310$8.68
$2.69kSell
Scott BizilyChief Legal Officer2025-12-161,635$10.90
$17.82kSell
Scott BizilyChief Legal Officer2025-12-161,635$4.14
$6.77kBuy
Charles TheuerDirector2025-12-129,333$1.14
$10.64kBuy
Scott BizilyChief Legal Officer2025-11-171,635$10.59
$17.31kSell
Scott BizilyChief Legal Officer2025-11-171,635$4.14
$6.77kBuy
Scott BizilyChief Legal Officer2025-10-242,678$12.00
$32.14kSell

1 of 2

FDMT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when FDMT insiders and whales buy or sell their stock.

FDMT Shareholders

What type of owners hold 4d Molecular Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ra Capital Management LP11.07%5,653,211$55.23MInstitution
Janus Henderson Group PLC9.08%4,635,875$45.29MInstitution
Bvf Inc9.07%4,629,289$45.23MInstitution
Ra Capital Management LP8.94%4,563,211$44.58MInsider
Goldman Sachs Group Inc 18.43%4,302,905$42.04MInstitution
Goldman Sachs Group Inc8.43%4,302,905$42.04MInstitution
Viking Global Investors LP8.32%4,247,914$41.50MInsider
Blackrock Inc7.96%4,064,876$39.71MInstitution
Novo Holdings A7.15%3,650,737$35.67MInstitution
Vanguard Group Inc6.06%3,093,527$30.22MInstitution

1 of 3

FDMT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
FDMT80.75%19.25%Net BuyingNet Selling
MDXG46.84%53.16%Net BuyingNet Buying
VALN2.99%0.00%
TRDA41.60%58.40%Net SellingNet Selling
LYEL0.49%99.51%Net BuyingNet Buying
View Top Biotech Stocks

4d Molecular Therapeutics Stock Ownership FAQ

Who owns 4d Molecular Therapeutics?

4d Molecular Therapeutics (NASDAQ: FDMT) is owned by 104.65% institutional shareholders, 24.94% 4d Molecular Therapeutics insiders, and 0.00% retail investors. Ra Capital Management LP is the largest individual 4d Molecular Therapeutics shareholder, owning 4.56M shares representing 8.94% of the company. Ra Capital Management LP's 4d Molecular Therapeutics shares are currently valued at $45.91M.

If you're new to stock investing, here's how to buy 4d Molecular Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.